B.P.L. PHARMACEUTICALS LTD versus COLLECTOR OF CENTRAL EXCISE, VADODARA
Selenium Sulfide Lotion U.S.P. ('Selsun') falls under tariff item 3003.19 as a medicine and not as a cosmetic, based on its therapeutic use, composition, labelling, literature, prescribing practices, and prior classification, with no material change in product character after enactment of Central Excise Tariff Act, 1985.
- Parties
- Appellant: B.P.L. Pharmaceuticals Ltd.; Respondent: Collector of Central Excise, Vadodara
- Jurisdiction
- India
- Judgment Date
- 04 May 1995
- Procedural Posture
- Civil Appeal / Appeal From CEGAT Orders 336 & 337/93 C Dated 29.10.93
- Outcome
- Appeals allowed; product classified as medicine under tariff item 3003.19.
- Legal Topics
- Classification Under Central Excise Tariff Act, Definition of Medicine Versus Cosmetic, Interpretation of Tariff Schedules
Case Brief
Summary, issues, holding and outcome
More case intelligence is available
Unlock the full research layer for this judgment.
Parties
B.P.L. Pharmaceuticals Ltd.
Appellant
Collector of Central Excise, Vadodara
Respondent
Procedural Posture
Civil Appeal / Appeal From CEGAT Orders 336 & 337/93 C Dated 29.10.93
Legal Issues
- 1 Whether 'Selenium Sulfide Lotion U.S.P.' is classifiable as a medicine or a cosmetic under Central Excise Tariff Act, 1985
- 2 Whether note 2 to Chapter 33 of Central Excise Tariff Act, 1985 applies to the disputed product
Ratio Decidendi
Selenium Sulfide Lotion U.S.P. ('Selsun') falls under tariff item 3003.19 as a medicine and not as a cosmetic, based on its therapeutic use, composition, labelling, literature, prescribing practices, and prior classification, with no material change in product character after enactment of Central Excise Tariff Act, 1985.
Court Disposition
Appeals allowed; product classified as medicine under tariff item 3003.19.
Orders
- Product 'Selsun' to be classified under tariff item 3003.19 as medicine.
- No order as to costs.
Full Case Text
Judgment text and source record
Sign in to read
Sign in to read the full judgment text
Sign in to read the full judgment text. Downloads and additional research tools may depend on your plan.
Sign in to read the full judgment